Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bryan King, MD, PhD
Seattle Children's Hospital
Principal Investigator - Craig Erikson, MD
Riley Hospital for Children
Principal Investigator - Elizabeth Berry-Kravis, MD, PhD
Rush University Medical Center
Principal Investigator - James McCracken, MD
University of California, Los Angeles
Principal Investigator - Jeremy Veenstra-VanderWeele, MD
Vanderbilt Kennedy Center
Principal Investigator - Jonathan Picker, MBChB, PhD
Boston Children's Hospital
Principal Investigator - Lawrence Ginsberg, MD
Red Oaks Psychiatry Associates, PA
Principal Investigator - Linmarie Sikich, MD
University of North Carolina Neurosciences Hospital
Principal Investigator - Randi Hagerman, MD
M.I.N.D. Institute
Principal Investigator - Raun Melmed, MD
Southwest Autism Research & Resource Center
Principal Investigator - Shivkumar Hatti, MD
Suburban Research Associates
Principal Investigator - Ted Brown, MD, PhD
NYS institute for Basic Research in Developmental Disabilities
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southwest Autism Research & Resource Center
Phoenix, Arizona, United States
- University of California-Los Angeles Neuropsychiatric Institute
Los Angeles, California, United States
- M.I.N.D. Institute
Sacramento, California, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Nys Institute for Basic Research in Developmental Disabilities
Staten Island, New York, United States
- University of North Carolina Neurosciences Hospital
Chapel Hill, North Carolina, United States
- Suburban Research Associates
Media, Pennsylvania, United States
- Vanderbilt Kennedy Center
Nashville, Tennessee, United States
- Red Oaks Psychiatry Associates, P.A.
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2008
- Primary completion
- 31 Mar 2010
- Completion
- 31 May 2010
- Last update posted
- 6 May 2013
- Registered enrollment
- 63
- Registry id
- NCT00788073
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.